WBEN reported that UB scientists, led by Jonathan Lovell, are working on a potential new vaccine to combat bird flu that might be easier to produce than egg-based vaccines.
A vaccine under development at UB, led by Jonathan Lovell, has demonstrated complete protection in mice for a deadly variant of the virus that causes bird flu.
The Independent reported that UB researchers, led by Jonathan Lovell, are developing a vaccine that has demonstrated complete protection in mice for a deadly variant of the virus that causes bird flu.
EIN Presswire reported that POP Biotechnologies, co-founded by Jonathan Lovell, will collaborate with UB to pursue the development of a unique vaccine approach against seasonal influenza.